DXCM vs NEOG · P/E 63, rev $2.50B vs rev $870.4M
DexCom Inc (DXCM) versus Neogen Corporation (NEOG) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Neogen Corporation (NEOG) is a diagnostics & research company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported NEOG revenue for 2026-05-31 was $870.4M. Net income was -$7.9M. Revenue was down 2.7% from 2025-05-31 to 2026-05-31. NEOG currently screens at market cap $1.03B.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. NEOG currently screens at market cap $1.03B.
Not investment advice. Open the DXCM and NEOG stock pages for the full models.
Not investment advice.